Recruiting
Phase 1

Ladarixin With Sotorasib in Advanced NSCLC

Sponsor:

NYU Langone Health

Code:

NCT05815173

Conditions

Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Sotorasib

Ladarixin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information